ERIC BRANDT
CIK 1190639 · Former EVP & CFO · last filed 2026-06-15
ERIC BRANDT is a Former EVP & CFO who has filed 243 SEC Form 4 insider transactions across 11 companies since 2007. The most recent filing shows the insider sold $20.0M of LRCX on Jun 15, 2026. Across all open-market trades the lifetime net is −$81.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $70.0M across reported positions. 3 SEC filings were submitted jointly with VERTEX PHARMACEUTICALS INC / MA.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$70.01M
11
243
-$81.82M
Filer Profile
4350 CUSHING PARKWAY
FREMONT, CA 94538
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LRCX | Director | 216,356 | $298.22 | $64.52M | -$47.03M | 22 | 2026-06-15 |
| OPCH | Director | 21,999 | $23.48 | $516.5K | $0 | 3 | 2026-05-22 |
| NTNX | Director | 6,698 | $65.92 | $441.5K | $0 | 2 | 2025-12-16 |
| GENVR | Director | 88,544 | $4.34 | $384.3K | $0 | 1 | 2025-09-11 |
| GEN | Director | 69,684 | $30.26 | $2.11M | $0 | 3 | 2024-09-13 |
| MAC | Director | 62,978 | $22.61 | $1.42M | $0 | 8 | 2024-06-03 |
| XRAY | Director | 58,772 | $10.46 | $614.8K | -$2.48M | 58 | 2024-04-15 |
| Gen Digital Inc. (NLOK) Delisted | Director | 46,306 | $21.66 | $1.00M | $0 | 5 | 2022-09-23 |
| BROADCOM CORP (BRCM) Delisted | Executive Vice President & CFO | 490,984 | — | — | -$31.40M | 53 | 2015-12-14 |
| VRTX | Director | 0 | $515.44 | $0 | -$907.5K | 3 | 2009-01-30 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | President, CEO & Director | 351,482 | — | — | $0 | 1 | 2007-03-07 |
Recent Filings
243 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | LRCX | Sell (S) | −54,500 | -$20.01M | EDGAR |
| 2026-06-15 | LRCX | Sell (S) | −54,500 | -$19.12M | EDGAR |
| 2026-06-12 | LRCX | Notice (144) | −54,500 | -$19.59M | EDGAR |
| 2026-06-11 | LRCX | Notice (144) | −54,500 | -$19.12M | EDGAR |
| 2026-05-22 | OPCH | Grant (A) | +11,640 | $58.8K | EDGAR |
| 2026-02-09 | LRCX | Sell (S) | −35,000 | -$7.90M | EDGAR |
| 2026-02-06 | LRCX | Notice (144) | −35,000 | -$7.90M | EDGAR |
| 2025-12-16 | NTNX | Grant (A) | +4,588 | $0 | EDGAR |
| 2025-11-10 | LRCX | Grant (A) | +1,635 | $0 | EDGAR |
| 2025-09-11 | GENVR | Mixed | +8,822 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.